Evidence mapPaperPMID 41560748Full record

ArticleFrontiers in pharmacology2025

Phytochemical characterization and pharmacological evaluation of aerial and root parts of

Mariana Andrea Peralta, Einy Nallybe Bedoya Aguirre, Melisa Fabiana Negro, Javier Echeverría, Maria Daniela Santi, Maria Gabriela Ortega

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mariana Andrea PeraltaFarmacognosia, Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
Einy Nallybe Bedoya AguirreFarmacognosia, Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
Melisa Fabiana NegroFarmacognosia, Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
Javier EcheverríaDepartamento de Ciencias del Ambiente, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago, Chile.
Maria Daniela SantiMax Planck Institute for Multidisciplinary Sciences, Goettingen, Germany.
Maria Gabriela OrtegaFarmacognosia, Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The Purpose: Considering the limited knowledge available on Material and Methods: Sequential extraction of Results and discussion: The chloroform extract (CDp) exhibited the most potent antifungal activity (minimum inhibitory concentration, MIC = 125 μg/mL), a relevant value considering that the reference drug fluconazole shows an MIC of 32 μg/mL in this resistant strain, underscoring the extract's significant activity despite azole resistance. CDp showed significant tyrosinase inhibition (half-maximal inhibitory concentration, IC Conclusion: This is the first chemical report of the EO and the deepening of prenylflavonoid content in different extracts of

Indexed as

antifungal bioactivityanti-tyrosinase activityDalea pazensisessential oilprenylflavanoids

Identifiers

PMID41560748
PMCPMC12812976

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.